These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24976230)

  • 41. [Editorial comment of: cryosurgery for prostate cancer: a comprehensive review].
    Banus Gassol JM
    Arch Esp Urol; 2013; 66(6):557. PubMed ID: 23985455
    [No Abstract]   [Full Text] [Related]  

  • 42. Editorial comment.
    Hermanson T; Sartor O; Ablin R; Bennett CL
    Urology; 2015 Feb; 85(2):413. PubMed ID: 25623704
    [No Abstract]   [Full Text] [Related]  

  • 43. Editorial comment.
    Drake C
    Urology; 2013 Jun; 81(6):1302. PubMed ID: 23582480
    [No Abstract]   [Full Text] [Related]  

  • 44. Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels.
    Eggener S
    Eur Urol; 2009 Mar; 55(3):616. PubMed ID: 18639973
    [No Abstract]   [Full Text] [Related]  

  • 45. Editorial comment to use of Chinese medicine among prostate cancer patients in Taiwan: a retrospective longitudinal cohort study.
    Yoshimura K
    Int J Urol; 2011 May; 18(5):387. PubMed ID: 21382099
    [No Abstract]   [Full Text] [Related]  

  • 46. Editorial comment. Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.
    Dalkin BL
    Urology; 2010 Nov; 76(5):1238; author reply 1238-9. PubMed ID: 21056273
    [No Abstract]   [Full Text] [Related]  

  • 47. Editorial comment.
    Pearcy R
    J Urol; 2009 Nov; 182(5):2302. PubMed ID: 19758654
    [No Abstract]   [Full Text] [Related]  

  • 48. Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Wu CT; Yang YH; Chen PC; Chen MF; Chen WC
    Osteoporos Int; 2015 Sep; 26(9):2281-90. PubMed ID: 25990353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial comment on: first analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer.
    Ficarra V; Novara G
    Eur Urol; 2008 Jun; 53(6):1201-2. PubMed ID: 17997014
    [No Abstract]   [Full Text] [Related]  

  • 50. Editorial comment.
    Shepard DR
    Urology; 2010 May; 75(5):1137. PubMed ID: 20451735
    [No Abstract]   [Full Text] [Related]  

  • 51. Editorial comment on: first analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer.
    Eastham JA
    Eur Urol; 2008 Jun; 53(6):1202-3. PubMed ID: 17997016
    [No Abstract]   [Full Text] [Related]  

  • 52. Editorial comment on: predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.
    Adolfsson J
    Eur Urol; 2008 Dec; 54(6):1304-5. PubMed ID: 18342429
    [No Abstract]   [Full Text] [Related]  

  • 53. Editorial comment.
    Blute ML
    Urology; 2011 Sep; 78(3):619; author reply 619. PubMed ID: 21884912
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial comment: Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Emberton M
    BJU Int; 2012 Dec; 110(11):1707-8. PubMed ID: 22928731
    [No Abstract]   [Full Text] [Related]  

  • 55. Editorial comment.
    Freedland SJ
    Urology; 2009 Sep; 74(3):516. PubMed ID: 19716903
    [No Abstract]   [Full Text] [Related]  

  • 56. Editorial comment.
    Froehner M
    J Urol; 2011 Mar; 185(3):839; author reply 840. PubMed ID: 21238991
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial comment.
    Alibhai SM
    J Urol; 2011 Mar; 185(3):839-40; author reply 840. PubMed ID: 21239005
    [No Abstract]   [Full Text] [Related]  

  • 58. Editorial comment to comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
    Costantini E; Mearini L
    Int J Urol; 2012 Sep; 19(9):844-5. PubMed ID: 22640746
    [No Abstract]   [Full Text] [Related]  

  • 59. Editorial Comment to Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.
    Bellardita L; Rancati T; Valdagni R
    Int J Urol; 2014 Apr; 21(4):375-6. PubMed ID: 24224716
    [No Abstract]   [Full Text] [Related]  

  • 60. [Spanish FRAX(®): pathing the way through walking].
    Naranjo A; Ojeda Bruno S
    Med Clin (Barc); 2015 Jan; 144(1):21-3. PubMed ID: 24629475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.